(lp0
S'Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial ... PR Newswire  - Jan 19, 2017 To participate in the conference call, please dial 1-888-771-4371  or 1-847-585-4405  and use passcode 44159815.'
p1
aS'Vanda Pharmaceuticals Announces Participation at March 2017 Investor Conferences PR Newswire  - Mar 6, 2017 WASHINGTON, March 6, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it will participate at the following upcoming investor conferences in March 2017.Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Announces Participation at ... - The Wall Street TranscriptVanda Pharmaceuticals Inc.  earnings expectations - The Independent Republic'
p2
aS'Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial ... PR Newswire  - Feb 10, 2016 10, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the fourth quarter and full year ended December 31, 2015.'
p3
aS"Vanda Pharmaceuticals Reports Third Quarter 2016 Financial Results PR Newswire  - Nov 2, 2016 WASHINGTON, Nov. 2, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the third quarter ended September 30, 2016.Vanda Pharmaceuticals'  CEO Mihael Polymeropoulos on Q3 2016 Results ... - Seeking Alpha"
p4
aS'Vanda Pharmaceuticals appoints Gian Piero Reverberi as Acting Chief Commercial ... PR Newswire  - Dec 17, 2015 WASHINGTON, Dec. 17, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it has appointed Gian Piero Reverberi to the role of Senior Vice President, Acting Chief Commercial Officer and European General&nbsp;...'
p5
aS'Vanda Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 17 Equities.com - Feb 17, 2017 Vanda Pharmaceuticals Inc.  traded on unusually high volume on Feb. 17, as the stock gained 3.45% to close at $15.00.Guess Who Picked Up Vanda Pharmaceuticals Inc.  Shares - Small Cap Exclusive Point72 Asset Management, LP Raises Stake in Vanda Pharmaceuticals, Inc. (VNDA ... - StreetInsider.com'
p6
aS"Vanda Pharmaceuticals Announces the Appointment of European General Manager PR Newswire  - Sep 8, 2015 8, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it has named Gian Piero Reverberi as Vanda's Senior Vice President, European General Manager."
p7
aS'Analyst Advice And Earnings Insight: Vanda Pharmaceuticals Inc. , The ... Post Analyst - Mar 17, 2017 Vanda Pharmaceuticals Inc.  revenue totaled $38.39 million down -0.23% from the previous quarter. The good news is, sales may return to growth this quarter.Federated Investors Inc. PA Buys 65059 Shares of Vanda Pharmaceuticals Inc.  - Chaffey Breeze'
p8
aS"Vanda Patents Found Valid and Infringed in Fanapt ANDA Litigation PR Newswire  - Aug 25, 2016 WASHINGTON, Aug. 25, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that Judge Gregory M. Sleet of the United States District Court for the District of Delaware ruled that Roxane Laboratories Inc. &nbsp;...Brean Capital Take on Vanda Pharmaceuticals Inc.'s  Patent Win; Raises ... - Smarter AnalystVanda Pharmaceuticals  Stock Soars on Drug Patent Ruling - TheStreet.com"
p9
aS"Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals PR Newswire  - Dec 18, 2015 WASHINGTON, Dec. 18, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , announced today that Kenneth Bate, an independent biotechnology industry consultant, has joined Vanda's Board of Directors."
p10
a.